Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tonapofylline is an orally active and selective antagonist of the A1 adenosine receptor (Ki: 7.4 nM for human A1). Tonapofylline can be used in studies about heart failure.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 60.00 | |
5 mg | In stock | $ 147.00 | |
10 mg | In stock | $ 237.00 | |
25 mg | In stock | $ 476.00 | |
50 mg | In stock | $ 691.00 | |
100 mg | In stock | $ 983.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 162.00 |
Description | Tonapofylline is an orally active and selective antagonist of the A1 adenosine receptor (Ki: 7.4 nM for human A1). Tonapofylline can be used in studies about heart failure. |
Targets&IC50 | A1 receptor (human):(ki)7.4 nM |
In vivo | Tonapofylline (1 mg/kg; p.o.) sustainably reduces the levels of post-Cisplatin serum creatinine and blood urea nitrogen and improves body weight recovery and significant attenuation of Cisplatin-induced (5.5 mg/kg) kidney pathology scores [3]. |
Synonyms | BG 9928 |
Molecular Weight | 416.51 |
Formula | C22H32N4O4 |
CAS No. | 340021-17-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 90 mg/mL (216.1 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tonapofylline 340021-17-2 GPCR/G Protein Neuroscience Adenosine Receptor BG-9928 BG 9928 BG9928 inhibitor inhibit